Literature DB >> 19199822

Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency.

Grant D Trobridge1, James Allen, Laura Peterson, Christina Ironside, David W Russell, Hans-Peter Kiem.   

Abstract

Foamy viral vectors and lentiviral vectors are attractive gene transfer vectors for hematopoietic stem cell gene therapy because they both efficiently transduce stem cells using rapid ex vivo transduction protocols designed to maintain engraftment potential. Here we directly compared the ability of foamy and lentiviral vectors to transduce long-term hematopoietic repopulating cells in the dog model, using a competitive repopulation assay with vectors that express enhanced yellow or green fluorescent proteins (EY/GFP). Mobilized canine peripheral blood CD34(+) cells were divided into two fractions and exposed to either foamy (EGFP) or lentiviral (EYFP) vectors at a multiplicity of infection of 5 in an 18-hr transduction protocol and then reinfused after conditioning with 920 cGy of total body irradiation. Both dogs studied had rapid neutrophil engraftment and multilineage engraftment of transduced cells. Marking was similar for both vectors, particularly at later time points, indicating that both vector types transduce long-term repopulating cells at similar frequencies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199822      PMCID: PMC2828621          DOI: 10.1089/hum.2008.170

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  21 in total

1.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Christof von Kalle; Manfred Schmidt; Françoise Le Deist; Nicolas Wulffraat; Elisabeth McIntyre; Isabelle Radford; Jean-Luc Villeval; Christopher C Fraser; Marina Cavazzana-Calvo; Alain Fischer
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

2.  Pharmacologically regulated in vivo selection in a large animal.

Authors:  Tobias Neff; Peter A Horn; Victor E Valli; Allen M Gown; Scott Wardwell; Brent L Wood; Christof von Kalle; Manfred Schmidt; Laura J Peterson; Julia C Morris; Robert E Richard; Tim Clackson; Hans-Peter Kiem; C Anthony Blau
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

Review 3.  The foamy viruses.

Authors:  J J Hooks; C J Gibbs
Journal:  Bacteriol Rev       Date:  1975-09

4.  Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors.

Authors:  M Goerner; P A Horn; L Peterson; P Kurre; R Storb; J E Rasko; H P Kiem
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

5.  Improved foamy virus vectors with minimal viral sequences.

Authors:  Grant Trobridge; Neil Josephson; George Vassilopoulos; Jaclynn Mac; David W Russell
Journal:  Mol Ther       Date:  2002-09       Impact factor: 11.454

6.  A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses.

Authors:  Paul C Hendrie; Yunwen Huo; Raisa B Stolitenko; David W Russell
Journal:  Mol Ther       Date:  2008-01-22       Impact factor: 11.454

7.  Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol.

Authors:  Peter A Horn; Kirsten A Keyser; Laura J Peterson; Tobias Neff; Bobbie M Thomasson; Jesse Thompson; Hans-Peter Kiem
Journal:  Blood       Date:  2004-01-22       Impact factor: 22.113

8.  Kinetics of fluorescence expression in nonhuman primates transplanted with GFP retrovirus-modified CD34 cells.

Authors:  Peter Kurre; Julia Morris; Robert G Andrews; Donald B Kohn; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2002-07       Impact factor: 11.454

Review 9.  Replication of primate foamy viruses in natural and experimental hosts.

Authors:  V Falcone; M Schweizer; D Neumann-Haefelin
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

10.  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Authors:  Alessandro Aiuti; Shimon Slavin; Memet Aker; Francesca Ficara; Sara Deola; Alessandra Mortellaro; Shoshana Morecki; Grazia Andolfi; Antonella Tabucchi; Filippo Carlucci; Enrico Marinello; Federica Cattaneo; Sergio Vai; Paolo Servida; Roberto Miniero; Maria Grazia Roncarolo; Claudio Bordignon
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  17 in total

Review 1.  Hematopoietic-stem-cell-based gene therapy for HIV disease.

Authors:  Hans-Peter Kiem; Keith R Jerome; Steven G Deeks; Joseph M McCune
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.

Authors:  Patrick M Younan; Christopher W Peterson; Patricia Polacino; John P Kowalski; Willimark Obenza; Hannah W Miller; Brian P Milless; Phil Gafken; Stephen C DeRosa; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2015-02-04       Impact factor: 11.454

Review 3.  Large animal models of hematopoietic stem cell gene therapy.

Authors:  G D Trobridge; H-P Kiem
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

4.  Tracking of specific integrant clones in dogs treated with foamy virus vectors.

Authors:  Ken Ohmine; Yi Li; Thomas R Bauer; Dennis D Hickstein; David W Russell
Journal:  Hum Gene Ther       Date:  2010-12-19       Impact factor: 5.695

Review 5.  Ex vivo gene therapy for HIV-1 treatment.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Hum Mol Genet       Date:  2011-04-19       Impact factor: 6.150

6.  Autologous implantation of BMP2-expressing dermal fibroblasts to improve bone mineral density and architecture in rabbit long bones.

Authors:  Akikazu Ishihara; Steve E Weisbrode; Alicia L Bertone
Journal:  J Orthop Res       Date:  2015-08-12       Impact factor: 3.494

7.  Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Authors:  Olivier Humbert; Frieda Chan; Yogendra S Rajawat; Troy R Torgerson; Christopher R Burtner; Nicholas W Hubbard; Daniel Humphrys; Zachary K Norgaard; Patricia O'Donnell; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Peter J Felsburg; David J Rawlings; Hans-Peter Kiem
Journal:  Blood Adv       Date:  2018-05-08

Review 8.  Foamy virus vectors for gene transfer.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

9.  Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.

Authors:  Grant D Trobridge; Brian C Beard; Robert A Wu; Christina Ironside; Punam Malik; Hans-Peter Kiem
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 10.  Large animal models for foamy virus vector gene therapy.

Authors:  Grant D Trobridge; Peter A Horn; Brian C Beard; Hans-Peter Kiem
Journal:  Viruses       Date:  2012-12-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.